SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-328152
Filing Date
2021-11-12
Accepted
2021-11-12 16:31:10
Documents
12
Period of Report
2021-11-12
Items
Item 3.03: Material Modifications to Rights of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d258771d8k.htm   iXBRL 8-K 22807
  Complete submission text file 0001193125-21-328152.txt   147977

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cprx-20211112.xsd EX-101.SCH 2910
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20211112_lab.xml EX-101.LAB 18908
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20211112_pre.xml EX-101.PRE 11875
5 EXTRACTED XBRL INSTANCE DOCUMENT d258771d8k_htm.xml XML 3532
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 211404080
SIC: 2834 Pharmaceutical Preparations